tiprankstipranks
Trending News
More News >

Genetic Signatures Ltd. Announces Cessation of Securities

Story Highlights
Genetic Signatures Ltd. Announces Cessation of Securities

Don’t Miss TipRanks’ Half-Year Sale

Genetic Signatures Ltd. ( (AU:GSS) ) just unveiled an update.

Genetic Signatures Ltd. announced the cessation of 240,000 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may affect the company’s capital structure and could have implications for its financial strategy and stakeholder interests.

The most recent analyst rating on (AU:GSS) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on Genetic Signatures Ltd. stock, see the AU:GSS Stock Forecast page.

More about Genetic Signatures Ltd.

Genetic Signatures Ltd. operates in the biotechnology industry, focusing on the development of molecular diagnostics products. The company is known for its innovative solutions aimed at simplifying and accelerating the detection of infectious diseases, catering primarily to clinical laboratories and healthcare providers.

Average Trading Volume: 160,561

Technical Sentiment Signal: Sell

Current Market Cap: A$86.31M

For detailed information about GSS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1